Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-128590
Filing Date
2016-06-17
Accepted
2016-06-17 16:25:36
Documents
2
Period of Report
2016-06-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4197
2 POA DOCUMENT poa.txt EX-24.4_662734 3117
  Complete submission text file 0001209191-16-128590.txt   8716
Mailing Address 1601 TRAPELO ROAD SUITE 284 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 284 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Issuer) CIK: 0001598646 (see all company filings)

EIN.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MINERVA NEUROSCIENCES, INC. 245 FIRST STREET, SUITE 1800 CAMBRIDGE MA 02141
Business Address
Vandervelpen Nico (Reporting) CIK: 0001618165 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36517 | Film No.: 161720417